Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis
ABSTRACT Introduction Traumatic brain injury is a leading cause of death and disability. Tranexamic acid, an antifibrinolytic agent, holds the potential for managing intracranial hemorrhages secondary to traumatic brain injury. However, its efficacy and safety remain subjects of ongoing debate. O...
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2025-03-01
|
| Col·lecció: | Einstein (São Paulo) |
| Matèries: | |
| Accés en línia: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100401&lng=en&tlng=en |